Clinical Trial Update: Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nintedanib in locally advanced or metastatic neuroendocrine tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Neuroendocrine Neoplasm

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Carcinoid Tumor, Metastatic Carcinoid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2022-06-28